<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus are two agents which chronically infect man and have been associated with specific <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Such findings point the way to new methods of control and detection of human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, immunosuppression is another major factor underlying the development of certain <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in human populations </plain></SENT>
<SENT sid="3" pm="."><plain>It is clear that congenital <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> states as well as organ transplant recipients requiring iatrogenic immunosuppression and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients requiring chemotherapy and/or x-irradiation are susceptible to particular <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> at a higher rate than the <z:mpath ids='MPATH_458'>normal</z:mpath> population </plain></SENT>
<SENT sid="4" pm="."><plain>Such findings also provide not only clues as to the mechanisms which control <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development but argue for certain limitations to the extent of immunosuppressive therapy utilized for treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>